Apixaban vs. Rivaroxaban: Lower Bleeding Risk – Study
New research indicates that apixaban may be a safer option than rivaroxaban for individuals undergoing treatment for acute venous thromboembolism (VTE), which includes conditions like deep vein thrombosis and pulmonary embolism. A recent study published in The New England Journal of Medicine revealed a significantly lower risk of clinically relevant bleeding events among patients treated … Read more